The Destructive Effect of Ingroup Competition on Ingroup Favoritism

Ingroup favoritism has been widely verified in the context of intergroup competition; however, how competition among ingroup members affects ingroup favoritism remains unclear. We hypothesized that competition among ingroup members may disrupt individuals’ ingroup-favoring behavior because of conflicts of interest; we tested this hypothesis in two studies. In Study 1, we manipulated competitive intragroup outcome interdependence (present vs. absent) and the manner in which results were presented (public vs. anonymous). We found that regardless of result presentation, when competitive intragroup outcome interdependence was present, ingroup members did not exhibit ingroup favoritism; when such interdependence was absent, they showed ingroup favoritism. In Study 2, we introduced the manipulation of social identification, and reverified the main result that individuals under competitive intragroup outcome interdependence do not exhibit ingroup favoritism. Even the degree of social identification—a vital factor for intergroup behavior—could not moderate the destructive effect of competitive intragroup outcome interdependence on ingroup favoritism. Together, these findings indicate that ingroup favoritism would indeed be damaged by competition among ingroup members

Synchronous multiple primary malignancies of clear cell renal cell carcinoma with sarcomatoid, thyroid carcinoma: a case report

Multiple primary malignant neoplasms (MPMNs) are defined as the presence of two or more malignancies with different histologies in the same patient. MPMNs are rare, accounting for fewer than 4% of all tumor cases. Depending on the time interval between the diagnosis of the different malignancies, they are classified as either simultaneous or metachronous MPMNs, with simultaneous being rarer in MPMNs. Here, we present a 63-year-old female patient presenting with multiple primary renal and thyroid carcinomas and discuss the risk factors, treatment options, and prognosis of rare dual carcinomas. We focus on managing multidisciplinary teams and selecting individualized treatment options to deliver valuable treatment strategies to patients

Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma

) in which the transgene expression was under the transcriptional regulation of oriP promoter.. Immunohistochemistry was used to detect the expression and the activity of the IFNγ in tumor sections. Our results demonstrated that mc-oriP vectors mediated comparable gene expression and anti-proliferative effect in the EBV-positive NPC cell line C666-1 compared to mc-CMV vectors. Furthermore, mc-oriP vectors exhibited much lower killing effects on EBV-negative cell lines compared to mc-CMV vectors. The targeted expression of mc-oriP vectors was inhibited by EBNA1-siRNA in C666-1. This selective expression was corroborated in EBV-positive and -negative tumor models. as a safe and highly effective targeted gene therapeutic system for the treatment of EBV positive NPC

Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells

Background and objective Amorphigenin, a rotenoid compouns, from seeds of Amorpha fruticosa, has been shown to possess anti-proliferation activities in several cancer cells. To explore the antitumor effects of amorphigenin on cisplatin-resistant human lung adenocarcinoma A549/DDP cells and explore the underlying mechanisms. Methods CCK-8 assay was used to measure the proliferation of A549/DDP cells; Colony formation assay was used to measure the colony formation of A549/DDP cells; Flow cytometry assay was used to detect the apoptosis rates; Western blot analysis was used to explore the expression of apoptosis-related proteins (caspase-3 protein, PARP protein) and lung resistance protein (LRP). Results Our results demonstrated that amorphigenin could inhibit the proliferation of A549/DDP cells with a inhibition concentration of 50% cell growth (IC50) at 48 h of (2.19±0.92) μmol/L. Amorphigenin could inhibit the colony formation ability and induce apoptosis of A549/DDP cells; Furthermore, amorphigenin combined with cisplatin showed synergistic proliferation-inhibitory effect and apoptosis-promoting effect in A549/DDP cells; reduced the expression of LRP of A549/DDP cells. Conclusion Amorphigenin remarkably inhibits the proliferation and induces apoptosis in A549/DDP cells. Combination of amorphigenin with cisplatin had the synergistic inhibitory effect on A549/DDP cells by downregulating the expression of LRP

Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration

Abstract Oxidative stress refers to the process of reactive oxide species (ROS) increase in human body due to various factors, which leads to oxidative damage in human tissues. Current studies have confirmed that sustained oxidative stress is one of the distinctive features throughout the development of tumors. Numerous reports have shown that lncRNAs can regulate the process of oxidative stress through multiple pathways. However, the relationship between glioma-associated oxidative stress and lncRNAs is not clearly investigated. RNA sequencing data of GBM (glioblastoma) and LGG (low grade glioma) and corresponding clinical data were retrieved from the TCGA database. Oxidative stress related lncRNAs (ORLs) were identified by Pearson correlation analysis. Prognostic models for 6-ORLs were structured in the training cohort by univariate Cox regression analysis, multivariate Cox regression analysis and LASSO regression analysis. We constructed the nomogram and verified its predictive efficacy by Calibration curves and DCA decision curves. The biological functions and pathways of 6-ORLs-related mRNAs were inferred by Gene Set Enrichment Analysis. Immune cell abundance and immune function associated with risk score (RS) were estimated by ssGSEA, CIBERSORT and MCPcounter synthetically. External validation of the signature was completed using the CGGA-325 and CGGA-693 datasets. 6-ORLs signature—AC083864.2, AC107294.1, AL035446.1, CRNDE, LINC02600, and SNAI3-AS1—were identified through our analysis as being predictive of glioma prognosis. Kaplan–Meier and ROC curves indicated that the signature has a dependable predictive efficacy in the TCGA training cohort, validation cohort and CGGA-325/CGGA-693 test cohort. The 6-ORLs signature were verified to be independent prognostic predictors by multivariate cox regression and stratified survival analysis. Nomogram built with risk scores had strong predictive efficacy for patients' overall survival (OS). The outcomes of the functional enrichment analysis revealing potential molecular regulatory mechanisms for the 6-ORLs. Patients in the high-risk subgroup presented a significant immune microenvironment of macrophage M0 and cancer-associated fibroblast infiltration which was associated with a poorer prognosis. Finally, the expression levels of 6-ORLs in U87/U251/T98/U138 and HA1800 cell lines were verified by RT-qPCR. The nomogram in this study has been made available as a web version for clinicians. This 6-ORLs risk signature has the capabilities to predict the prognosis of glioma patients, assist in evaluating immune infiltration, and assess the efficacy of various anti-tumor systemic therapy regimens

Recent achievements of free‐standing material and interface optimization in high‐energy‐density flexible lithium batteries

Abstract Lithium‐based batteries are the most potential state‐of‐the‐art energy storage device for flexible electronics. The flexible lithium batteries have the advantages of high energy density, robust mechanical durability, and stable power output even under dynamic deformation. Among them, the synergies of flexible free‐standing electrodes, solid electrolytes, and electrode–electrolyte interfaces are crucial to achieving the goal of high energy density and safety performance for flexible lithium batteries. Therefore, a thorough understanding of the interface formation mechanism and influencing factors is crucial for the design of flexible electrodes and solid electrolytes. In this review, the interface challenges in flexible lithium‐based batteries including interface formation, electrodes‐electrolyte interface, and interparticle interface characteristics are presented. Then, strategies of interface optimization are summarized and discussed. Following this, the interface of flexible lithium‐based batteries with novel architecture is introduced, including the interface between each component and unit of the battery. Finally, the perspectives for the future development of flexible lithium‐based batteries are also given

Uncovering cortical activations of discourse comprehension and their overlaps with common large-scale neural networks

We conducted a meta-analysis of 78 task-based functional magnetic resonance imaging (fMRI) studies (1976 total participants) to reveal underlying brain activations and their overlap with large-scale neural networks in the brain during general discourse comprehension and its sub-processes. We found that discourse comprehension involved a neural system consisting of widely distributed brain regions that comprised not only the bilateral perisylvian language zones, but also regions in the superior and medial frontal cortex and the medial temporal lobe. Moreover, this neural system can be categorized into several sub-systems representing various sub-processes of discourse comprehension, with the left inferior frontal gyrus and middle temporal gyrus serving as core regions across all sub-processes. At a large-scale network level, we found that discourse comprehension relied most heavily on the default network, particularly on its dorsal medial subsystem. The pattern associated with large-scale network cooperation varied according to the respective sub-processes required. Our results reveal the functional dissociation within the discourse comprehension neural system and highlight the flexible involvements of large-scale networks.</p